~~<i id='04E6F120BC'><strike id='04E6F120BC'><tt id='04E6F120BC'><pre id='04E6F120BC'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：leisure time 2025-10-02 13:42:16 Page View：535

Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Problems with a popular proposal to regulate AI in health care
Next article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

explore

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

FILE-CarsentertheUltraLowEmissionZonethathascomeintoforceinLondon,Monday,April8,2019.ABritishcourtru

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

FILE-JapanesePrimeMinisterFumioKishidaispresentedtheInternationalAtomicEnergyAgency'scomprehensivere